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Abstract 
 Postoperative pain is of serious concern to patients and anesthesia providers alike.  
Management of a patients’ pain is a central component of anesthesia care.  Ketamine as an 
anesthetic agent has been available for 50 years.  It has been utilized as a general anesthetic and 
selectively as an anesthetic agent for high-risk patients.  Due to dysphoric side effects associated 
with the dosage required to render general anesthesia, anesthesia providers may be reluctant to 
utilize this medication to its full potential.  Recently there has been a resurgence of interest in 
ketamine as an analgesic agent. The researcher for this project performed a thorough literature 
review focusing on intravenous ketamine as an adjunct to standard opioid-based analgesia for 
postoperative pain.  Four systematic reviews published in the last 10 years support the safety and 
efficacy of ketamine when administered intravenously in sub-anesthetic doses.  The purpose of 
this project was to provide evidence-based education to anesthesia providers regarding the 
benefits of ketamine and follow-up to evaluate for evidence of changes in practice after the 
educational   At a large community hospital data concerning ketamine utilization by anesthesia 
providers as a component of multimodal analgesia was collected for a six-month period, 
including three months pre- and three months post-educational intervention.  Despite various 
methods utilized to present evidence regarding the safety and efficacy of ketamine, the results of 
this study demonstrated no significant change in practice. Based upon the extensive published 
literature the evidence is compelling that the addition of a sub-anesthetic (0.5 mg/kg) dose of 
ketamine to the surgical patient’s operative pain management plan would improve comfort and 
decrease opioid-related side effects with minimal negative impact. 
Keywords:  ketamine, postoperative, acute postoperative, pain, anesthesia, multimodal analgesia, 
adjunct agents, opioid, side effect
 Introduction 
Management of a patient’s pain is a central component of anesthesia care.  Postoperative pain is 
a challenge for anesthesia providers with opioids being a commonly used intervention.  Opioid-
related side effects, such as nausea and vomiting, along with respiratory depression, are well 
documented in the literature (Koneti & Jones, 2013).  Inadequate postoperative analgesia 
contributes to negative outcomes, such as hyperglycemia, immunosuppression, inadequate 
rehabilitation, and progression to chronic pain (Laskowski, Stirling, McKay & Lim, 2011).  
Adjunct therapies, including non-steroidal anti-inflammatory drugs (NSAID’s), acetaminophen, 
and anticonvulsants, such as gabapentin, have been shown to reduce postoperative opioid 
consumption (Laskowski et al., 2011).  Perioperative intravenous ketamine has been 
demonstrated to be a useful addition to multimodal analgesia for the surgical patient.  Overall 
pain management can be improved by adding medications that act at different sites in the pain 
pathway.  The anesthesia provider must balance the benefits of pain management medications 
with their potential side effects.  Ketamine has a different mechanism of action than opioids, 
working at the level of the N-Methyl-D-aspartate (NMDA) receptor.  There is considerable 
literature on the anesthetic and analgesic effects of ketamine, since it has been available for 50 
years (Persson, 2013).  However, anesthesia providers are still uncertain of its efficacy, 
concerned about its side effects, and may not have a full understanding of its safety profile when 
dosed accordingly for analgesia, as opposed to doses needed for anesthesia (Elia & Tramèr, 
2005; Schmid, Sandler & Katz, 1999).  The researcher for this project examined anesthesia 
providers’ practices regarding utilization of ketamine as an adjunct analgesic for surgical pain in 
light of evidence of its effectiveness and safety profile when administered in this dose range. 
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Background 
In 2010, over 51 million inpatient surgeries were performed in the United States.  
Excluding endoscopic, obstetric, and non-surgery-related diagnostic procedures, approximately 
20 million general surgeries were performed (Centers for Disease Control and Prevention 
[CDC], 2010).  The treatment of pain after surgery is a central component of postoperative care.  
It is unacceptable, both morally and ethically, to fail to relieve a patient’s pain, which may be 
regarded as the fifth vital sign and should be addressed with as much importance as other vital 
signs (Koneti & Jones, 2013).  Anesthesia providers are responsible for managing patients’ pain 
during the perioperative (pre, per, and postoperative) period.  A myriad of pain treatment options 
are available and it can be challenging for a clinician to formulate a rational treatment plan (Soto 
& Fu, 2003).  Poorly controlled postoperative pain is distressing to the patient.  In addition to 
distress, patients may develop hyperglycemia, immunosuppression, infection, skin ulcers, and 
venous thrombosis as a result of inadequately controlled postoperative pain (Laskowski et al., 
2011; Rakic & Golembiewski, 2009).  There is growing concern that poorly controlled acute 
pain affects the development of long-term chronic pain (Wilder-Smith & Arendt-Nielsen, 2006).  
It is important that anesthesia providers have the most up-to-date information on all available 
pain management therapies in their armamentarium to enable them to best care for their patients. 
Opioids 
 The use of opium as a drug dates back thousands of years BC and archeology hints that 
the Neanderthals used the opium poppy over 30,000 years ago (Dickenson & Kieffer, 2006). 
Opioids are a mainstay of surgical pain management.  They can be utilized alone or in 
combination with other medications to provide multimodal analgesia.  Modern opioids such as 
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morphine, hydromorphone and fentanyl are routinely used for pain management in surgical 
patients.  Opioids’ produce analgesia, which is the absence or relief of pain, as well as euphoria 
and sedation (Stoelting & Hillier, 2006).  Common opioid-related side effects include respiratory 
depression, nausea, vomiting, and constipation.  Multimodal analgesia may reduce opioid 
consumption and, therefore, reduce some of these side effects.  The goal of multimodal analgesia 
is to administer two or more classes of drugs concurrently to achieve the benefits of synergy with 
a reduction in side effects (Soto & Fu, 2003).  With that aim in mind the anesthesia provider 
should consider all classes of drugs that provide analgesia in planning for the prevention and 
treatment of surgical pain.  
Ketamine 
 Ketamine is a derivative of phencyclidine (PCP), which produces dissociative anesthesia.  
In dissociative anesthesia the patient is amnestic, has an absence of pain, and they may appear 
awake, with eyes open (Stoelting & Hillier, 2006).  Ketamine first appeared in the literature in 
the early 1960’s and was approved for use as a general anesthetic in 1965.  It was the early 
1970’s before it was suggested to utilize sub-dissociative doses as an analgesic (Sadove, 
Shulman, Hatano & Fevold, 1971).  Despite being used for this period of time, it was not until 
1982 that Lodge and colleagues demonstrated ketamine’s mechanism of action as an NMDA 
receptor antagonist (as cited in Persson, 2013).  The NMDA receptor has been identified as 
processing nocioceptive input, which contributes to the response of pain.  Acute postoperative 
pain is considered to be nocioceptive pain (Koneti & Jones 2013).  Over time ketamine fell out 
of favor with practitioners due to its dysphoric side effects, postoperative delirium and potential 
for hallucinations (Rakic & Golembiewski, 2009).  Ketamine also has abuse potential which is a 
concern for clinicians.  There is now a large body of research regarding the analgesic use of 
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ketamine in sub-anesthetic doses to optimize postoperative pain management in the surgical 
patient.  
  Bell, Dahl, Moore and Kalso (2006) conducted a systematic review for the Cochrane 
collaboration.  The results indicated that treatment with ketamine reduced morphine consumption 
and decreased postoperative nausea and vomiting (PONV) with mild or no side effects.  
Laskowski et al. (2011) conducted a systematic review, narrowing the inclusion criteria of 
studies to address the issues of heterogeneity.  Laskowski and colleagues included only studies in 
which ketamine was administered intravenously.  The results indicated that intravenous ketamine 
is an effective adjunct for postoperative pain particularly for painful surgeries. 
Problem 
Postoperative pain is a serious issue of concern to anesthesia providers and their patients.  
Ketamine is an analgesic agent, which can be utilized to assist in both the reduction of 
postoperative pain and the side effects of opioid medications.  Because of the possibility of 
untoward side effects and abuse potential of ketamine, along with previous studies with 
conflicting results, anesthesia providers may not use this agent to its maximum therapeutic 
benefit.  The PICO statement for this project is: (P) Do anesthesia providers caring for surgical 
patients at a 335-bed community hospital when (I) presented with high-level evidence of the 
effectiveness of low-dose ketamine (O) change their utilization of this drug?  Low-dose ketamine 
may be defined as sub-anesthetic (Rakic & Golembiewski, 2009), sub-dissociative (Sadove et al. 
1971), or for clinical purposes, a bolus dose of less than 1mg/kg administered intravenously 
(Schmid et al., 1999). 
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Project Purpose 
The researcher for this project assisted in translating evidence into practice based on: (1) 
the high-quality nature of the evidence, (2) the desire of anesthesia providers to provide the best 
possible care to their patients and  (3) utilization of adult learning strategies to facilitate change 
(Zaccagnini & Waud White, 2011).  Research is available and the evidence is of high quality 
suitable for presentation.  Numerous randomized controlled trials (RCTs) and several systematic 
reviews (SRs) have been published in the last 10 years.  As an anesthesia provider at the project 
facility in which this study was conducted, the researcher had the opportunity to present new 
knowledge to both anesthesia students and professional colleagues in the anesthesia specialty.  
Dissemination of information in various formats did not involve cost to the facility or the 
anesthesia group practice.  Change in practice patterns can be evaluated over time with 
additional reinforcement provided as necessary.  The electronic medical record system in use 
allows for analysis of ketamine usage over time in relation to number of surgeries by type, and 
by provider.  Evidence shows that “low dose” perioperative administration of ketamine can 
decrease opioid consumption and reduce negative side effects associated with opioids.  This 
project had a goal to increase anesthesia providers’ awareness of the benefits of ketamine as part 
of their multimodal pain management plan.  Increased utilization of ketamine, based on evidence 
may have a positive impact on surgical patients pain management. 
Definition of Terms 
Analgesia:  The absence of pain in response to noxious stimuli (Brown, 2009). 
Clinical Heterogeneity:  When differences in the patient population, outcome measures, 
definition of variables, and/or duration of follow-up of the studies included in the analysis 
create problems of non-compatibility (Petrie & Sabin, 2009).  
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Dissociative Anesthesia:  “A state characterized by analgesia and changes in vigilance 
and perception, but not frank sedation or hypnosis”….  “They are unconscious, amnestic 
and deeply analgesic” (Berti, Baciarello, Troglio & Fanelli 2009, p. 708). A trance-like 
state (Berti et al., 2009).  
Multimodal Therapy:  Multiple drugs are utilized in order to leverage on their additive 
and especially, synergistic effects (Soto & Fu, 2003).  
Nocioception:  “Nocioceptors are free nerve ending receptors present in the skin, 
muscles, joints, viscera and vasculature. These nocioceptors are responsible for detecting 
the presence of noxious stimuli” and the communication of pain to the spinal cord 
(Stoelting & Hillier, 2006, p. 709). 
NSAIDS:  “NSAID is an all inclusive term denoting a varied group of drugs possessing 
analgesic, anti-inflammatory, and antipyretic effects” (Stoelting & Hillier, 2006, p. 276).  
These drugs inhibit the Cyclooxygenase (COX) enzyme.  Examples include, ibuprofen, 
acetaminophen, ketorolac and aspirin.  
Opioids:  All exogenous substances, synthetic and natural, that bind to opioid receptors 
producing morphine-like effects.  Morphine, fentanyl, and hydromorphone are examples 
(Stoelting & Hillier, 2006). 
 Receptor Antagonist:  “Drugs that are antagonists inhibit or prevent receptor mediated 
agonists effects by competing for receptor occupancy” (Shafer & Schwinn, 2005, p. 86). 
Summary 
Management of postoperative pain is of critical importance to patients and their 
anesthesia providers.  Side effects of opioid medications can impact the utilization of this class of 
medications.  Multimodal analgesia aims to administer more than one class of medication, acting 
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on different sites in the pain pathway. This technique allows for better pain management with 
fewer side effects.  Evidence exists which indicates that ketamine is a safe and effective addition 
to a pain management regimen. The researcher for this project will present evidence to 
anesthesia providers regarding the efficacy and safety of  “low dose” ketamine in the treatment 
of postoperative surgical pain. 
Review of Literature 
Sources and Search Process 
 The aim of this researcher’s literature search was to identify the most current, high-
quality evidence regarding the utilization of ketamine for postoperative pain.  For this review, the 
researcher searched the Cochrane, Medline, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Pub Med and UNF One Search databases.  The researcher used the 
following terms in various combinations: perioperative, ketamine, postoperative, acute 
postoperative, pain, analgesia, pre-emptive, randomized control trial, meta-analysis and 
systematic review.  The researcher limited the searches to the years 2002 through 2013, the 
English language, and adults.  Additionally, the researcher performed a manual search of 
citations from relevant articles.  The search yielded four systematic reviews published between 
2004 and 2011 addressing the role of ketamine in multimodal analgesia.   As the last systematic 
review included studies only through 2010, the researcher conducted an additional search for 
RCT’s from 2010 through 2013.  See Figure 1 for a flow diagram of this researcher’s article 
selection process for systematic reviews.  (See Appendix A for Table 1)  The assessment of 
multiple systematic reviews (AMSTAR) measurement tool created to assess the methodological 
quality of systematic reviews conducted by Bell et al. (2006), Elia and Tramèr (2005), Laskowski 
et al. (2011), and Subramaniam, Subramaniam, and Steinbrook (2004).  
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Figure 1. Flow diagram of article selection process for systematic reviews. Adapted from 
“Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement,” 
by D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman DG, and The PRISMA Group, 2009, PLoS 
Med 6(7), e1000097. 
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Evaluation of Data-Extraction Tool 
 Table 1, (see Appendix A) provides information about the overall assessment of the four 
systematic reviews evaluating ketamine for acute postoperative pain. The researcher for this 
study used the assessment of multiple systematic reviews (AMSTAR) tool to perform the data 
extraction.  The AMSTAR tool lists one of the eleven elements as “were the characteristics of 
the included studies provided?”  (Shea et al., 2007, p. 5). 
 In an aggregated form such as a table, data from the studies should be provided on the 
participants, interventions and outcomes.  The ranges of characteristics in all studies 
analyzed e.g. age, race, sex, relevant socioeconomic data, disease status, duration, 
severity, or other diseases should be reported (Shea et al., 2007, p. 5).   
Utilizing this detailed definition none of the four systematic reviews met this one particular 
criteria item.  Demographic information from the reviewed studies was generally not reported.  
Bell et al. (2006) included interventions, outcomes and types of surgeries.  Elia and Tramèr 
(2005) included an online appendix which detailed dosages, methods of administration, types of 
operations, and outcomes.  Laskowski et al. (2011) included age, dose, mode of delivery, timing, 
surgical site and outcome and Subramaniam et al. (2004) included dosage, mode of delivery, 
timing and type of surgery. 
Meta-Analyses 
Laskowski et al. (2011) performed a systematic review including meta-analysis of 
RCTs that specifically looked at intravenous ketamine for postoperative analgesia. Previous 
systematic reviews included a range of doses and routes of administration for ketamine with 
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some inconclusive results related to the wide heterogeneity of the studies. Utilizing the same 
search strategy as Bell et al. (2006), Laskowski et al. found 70 studies for review from 1996 to 
2010 involving 4,701 patients specific for intravenous (iv) ketamine as an adjunct analgesic.  
Additionally, Laskowski et al. excluded studies in which regional anesthesia was involved.  
Forty-seven of these core studies could be quantifiably analyzed.  The primary outcome of total 
opioid consumption using a random effects model demonstrated a standard difference in means 
(SDM) of -0.631 (95% CI = -0.802 to -0.459; P < 0.001), thus, providing evidence of the 
opioid sparing effect of adjunctive ketamine.  Subgroup analysis showed no difference in 
opioid sparing in dosages ranging from 0.5 mg/kg to > 1 mg/kg.  The most significant reduction 
in opioid consumption was in upper abdominal and thoracic surgery.  Surgeries with higher 
postoperative pain scores demonstrated the greatest efficacy of ketamine. This was consistent 
with findings by Subramaniam et al. (2004). Evaluation of pain scores demonstrated that 78% 
of the placebo group experienced more pain despite higher opioid consumption. With 
increased opioid sparing, there was less PONV, but also an increase in neuropsychiatric side 
effects such as hallucinations and nightmares.   
Bell et al. (2006) published a Cochrane review on the perioperative effects of ketamine 
for acute postoperative pain.  The purpose of this review was to evaluate the evidence regarding 
ketamine in the perioperative period, its efficacy, and tolerability.  Bell et al. (2006) concluded 
that a sub-anesthetic dose of ketamine reduced morphine requirements in the first 24 hours 
following surgery.  The addition of ketamine reduced PONV and produced mild to no side 
effects.  This review included 37 trials with 53 treatment arms including 2240 participants.  Bell 
et al. (2006) reference both Subramaniam et al. (2004) and Elia and Tramèr (2005) systematic 
reviews that were published while preparing their review.  Bell et al. (2006) note that due to 
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heterogeneity of data they chose to restrict quantitative analysis to 24-hour patient controlled 
analgesia (PCA) consumption and PONV, excluding visual analog pain scores (VAS), as 
utilized by Subramaniam et al. (2004).  Elia and Tramèr (2005) produced similar findings 
regarding the efficacy of intravenous ketamine with both of these reviews including studies 
performed in children which were excluded from this review. 
Elia and Tramèr (2005) performed a systematic review of ketamine including RCTs 
that reported on opioid sparing, pain outcomes, and adverse effects. The published abstract of 
this study concludes with the statement, “Despite many published randomized trials, the role 
of ketamine, as a component of perioperative analgesia, remains unclear”  (p. 61). Due to the 
heterogeneity of studies, clinicians who delve no farther into the body of this systematic 
review could miss key findings that support the positive impact of ketamine when used 
intravenously.  This review included 53 RCTs from 23 countries. Of these, in 16 studies, the 
route of administration was intravenous, with a median ketamine dose across all trials of 
0.4mg/kg. Ten of these studies reported on pain intensity at rest with a consistent, statistically-
significant decrease in VAS scores at 6, 12, 24, and 48 hours postoperatively. Four studies 
suitable for meta-analysis looking at morphine consumption demonstrated the weighted mean 
difference (WMD) in favor of ketamine of -16 mg. There were seven studies reporting on the 
amount of time to first analgesic request demonstrating an average improvement with 
ketamine of about 16 minutes. Although the overall conclusion of this systematic review was 
that the role of ketamine as a component of perioperative analgesia was unclear this was due to 
heterogeneity of  the included studies.  The findings regarding intravenous ketamine were 
favorable, demonstrating a decrease in pain intensity at rest, decrease in cumulative 24 hour 
morphine consumption and an average improvement in time to first analgesic request. 
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Due to the varied modes of ketamine administration in RCTs, Subramaniam et al. 
(2004) performed both a quantitative and a qualitative analysis including only intravenous and 
epidural administration.  They excluded studies comparing pre-incision versus post-incision 
administration alone. This systematic review concluded that small-dose ketamine was useful and 
a safe adjunct to standard opioid-based analgesia.  A single dose of IV ketamine improved 
analgesia postoperatively in combination with opioids with no increase in side effects. 
The breadth of the studies, countries, and clinical settings, building on 50 years of 
reported outcomes, demonstrate the large worldwide interest in this drug.  All four of these 
systematic reviews published in the last 10 years provide evidence of the efficacy and safety of 
ketamine when administered intravenously in sub-anesthetic doses. The compilation of this 
body of evidence supports its consideration by anesthesia providers as an adjunct analgesic in 
the perioperative period. 
Summary 
In summary, the evidence from these clinical trials and systematic reviews demonstrate 
the efficacy of intravenous low-dose ketamine.  The evidence supports the use of low-dose 
intravenous ketamine to decrease postoperative pain and opioid consumption, as well as related 
opioid-induced side effects.  Ketamine side effects were reported as minimal to none.  This 
information will be disseminated to anesthesia providers in an effort to continuously improve 
management of a patients’ postoperative pain through evidence-based practice. 
Methodology 
 In this section, the researcher for this study includes a description of the study design, 
sample, and data collection tool that was utilized for this project.  There will be a discussion of 
the interventions provided and the theoretical model behind them.  The purpose of this project 
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was to provide evidence-based education to anesthesia providers regarding the adjunct utilization 
of intravenous ketamine and monitor for post educational changes in practice. 
Design and Setting 
The researcher for this study utilized a pre- and post-intervention single-center study 
review to assess for significant change in administration practices.  Data were collected from 
October through December 2013 in a retrospective fashion, utilizing surgical information system 
(SIS) analytics software.  The researcher conducted intervention in January 2014 via article 
dissemination and discussion, poster format and continuing education following the adult 
learning theory model.  Continuing education consisted of a presentation on the history of 
ketamine, literature search process, findings and the benefits of low-dose ketamine in the 
surgical patient population.   This was a self-study multi media format consisting of written 
literature, poster review, a Prezi ® software presentation followed by a ten item test.   The 
researcher was available throughout the process to answer questions.   For clarity, both the poster 
and the continuing education offering defined “low dose”, “sub-anasthetic” ketamine as 
0.5mg/kg iv. Utilizing the same analytics software, the researcher retrospectively collected data 
for January through March 2014.  Anesthesia providers were blinded to the fact that pre- and 
post- data collection was occurring. 
 The setting for this study was a large, 335-bed community hospital in the southeastern 
United States with a privately contracted anesthesia group.  This anesthesia group consisted of 
certified registered nurse anesthetists (CRNA’s), anesthesiologists (full-time and as needed) and 
an anesthesiologist assistant who made independent decisions regarding anesthetic 
administration. 
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Sample 
 The researcher for this study conducted a pre- and post-intervention retrospective 
analysis of approximately 900 anesthetics per month administered by roughly 25 providers to 
determine the percentage of general anesthetics that included the drug ketamine.  The researcher 
obtained permission to conduct this study from the investigator’s project committee, the 
Institutional Review Board (IRB) at the University of North Florida, the facility IRB, and the 
president of the anesthesia group (see Appendix B, Appendix C, and Appendix D for this 
documentation). 
Methods 
 The researcher for this study collected all data from October through December 2013 and 
January through March 2014.  Evidence-based educational intervention occurred during January 
2014.  Utilizing analytics software, the researcher reviewed all charts with the exclusion of those 
identified as endoscopy procedures, (see Appendix E for this list) which are not reflective of 
patients undergoing general anesthesia with the potential for postoperative pain.  Anesthetics 
administered by this investigator were also excluded to avoid potential bias.  
Data Collection 
 The researcher for this study collected all data from October through December 2013 and 
January through March 2014.  The researcher exported the raw data from analytic software to 
Microsoft Excel. The software reporting system to collect this data was only available to the 
principal investigator (PI).  The researcher collected provider names to allow for further analysis 
if warranted.  The researcher kept this information confidential. 
Feasibility  
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 This project was designed to evaluate the impact of the dissemination of high-level 
evidence regarding the benefits of intravenous ketamine to anesthesia providers in their practice.  
It is assumed that anesthesia providers have a desire to provide the highest level of care to their 
patients.  The alleviation of pain is a primary component of anesthesia care.  Over 90% of all 
CRNA’s are members of the AANA that is routinely providing evidence-based practice related 
documents to the membership.  
Income and Expenses 
 The primary expense for this project was the licensing of SIS analytics software.  The 
anesthesia group incurred this cost of $1,500.  The investigator incurred minimal printing and 
poster presentation costs. 
Protection of Human Subjects 
 The researcher for this study evaluated data from existing patient charts.  Ketamine is a 
formulary drug that is presently administered at the providers’ discretion.  Any increase in 
ketamine utilization post intervention has been show by the evidence to be of patient benefit, 
with minimal risk of side effects.  Anesthesia providers are routinely provided with evidence-
based education, therefore the intervention caused no harm to providers or patients.  
Confidentiality 
 Data obtained from the SIS analytics program did not identify individual patients in any 
format.  Anesthesia providers’ drug utilization was collected individually.  All results were 
reported in the aggregate, so no individual providers’ practices were reported.  The researcher for 
this study entered the Excel spreadsheet information into an encrypted external drive, which 
remained either with the principal investigator (on her person) or in a locked file cabinet in a 
secure location. 
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Data Analysis Plan 
All data were transferred to an Excel spreadsheet and checked for errors.  The researcher 
analyzed the data utilizing JMP® 10 software to perform a Pearson Chi square test between 
percentage of utilization between the pre- and post-intervention samples to determine whether 
there was a statistically significant difference in drug utilization.  All data were reported in the 
aggregate.  There was no discrepancy in the providers’ practicing pre- and post-intervention, so 
no additional analysis was required. 
Results 
 In this section, the researcher provides a description of the sample of records that met 
inclusion criteria.  Records that were excluded based on procedure type are outlined in detail.  
The total number of anesthetics that met the inclusion criteria are identified along with those 
receiving ketamine as a component of their general anesthetic.  
Sample Characteristics 
The researcher included for the analysis the medical records of all patients receiving 
anesthesia during a six-month period.  Thirty-eight of 726 coded procedures were excluded from 
analysis, as these were endoscopic procedures not reflective of general surgery post-operative 
pain management needs.  See Appendix D for a complete list of excluded procedures.  Of the 
anesthetics administered, 226 were excluded as they reflected anesthetics administered by the 
principal investigator.  The researcher included the remaining 3,618 cases for review of ketamine 
utilization. 
Quarterly Data 
During the three months prior to the educational intervention, a total of 2,701 anesthetics 
were administered.  Of these anesthetics, 1,796 met the inclusion criteria for this study.  Of these 
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1,796 anesthetics, ketamine was administered in 106 cases.  In the three-month period following 
the educational intervention, a total of 2,677 anesthetics were administered.  Of these anesthetics 
1,822 met the inclusion criteria for this study.  Of these, ketamine was administered in 107 cases 
(See figure 2.) 
 
Figure 2.  Total cases included for study and those including ketamine.  This bar graph compares 
the anesthetics and administration of ketamine from the Q4, 2013 pre-intervention period to the 
Q 1, 2014 post-intervention period. 
 
 
Discussion 
In this section, the researcher for this study provides a discussion of the project outcomes 
as related to anesthesia providers’ utilization of ketamine as an adjunct analgesic for 
postoperative pain following dissemination of evidence.  The limitations of the study, 
implications for the dissemination of evidence, challenges to effecting change, and 
recommendations for future projects are also presented.  
Management of a patient’s pain is a central component of anesthesia care with opioids 
being a commonly used intervention.  Opioid side effects, such as nausea and vomiting along 
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with respiratory depression, are well documented in the literature (Koneti & Jones, 2013).  
There is ample evidence from systematic reviews that ketamine, when utilized in sub-anesthetic 
doses, decreases post-operative pain, decreases opioid consumption and its associated side 
effects, with minimal to no adverse side effects (Bell et al., 2006; Elia & Tramèr, 2005; 
Laskowski et al., 2011; Subramaniam et al., 2004).   
The purpose of this project was to examine anesthesia providers’ practices regarding 
utilization of ketamine as an adjunct analgesic for surgical pain in light of evidence of its 
effectiveness and safety when administered intravenously in an analgesic (0.5mg/kg) range.  
Specifically, the researcher for this project evaluated if anesthesia providers at a large 
community hospital changed their utilization of ketamine following dissemination of evidence 
of its efficacy and safety when administered in sub-anesthetic doses.  Dissemination methods 
included journal club, poster presentation, and continuing education.  Although the 
dissemination of information appeared, subjectively, to be well received, and anesthesia 
providers have been shown to change practice based on evidence, there was no statistically 
significant change in practice noted during the period of this study (p=0.9701).  Thus the results 
of this study do not provide evidence that the dissemination of high quality systematic reviews 
supporting the use of ketamine as an adjunct analgesic altered anesthesia providers’ practices.  It 
is possible that providers were already administering ketamine to the patient population they 
deemed maximally appropriate based on recent evidence.  Another consideration would be the 
delivery method of information.  Possibly it was not compelling or engaging enough to change 
practice patterns. 
Limitations 
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This project had some limitations that should be noted.  Although the sample size was 
robust, the number of providers that were subject to evidence dissemination and the wide range 
of anesthetics administered by them may have diluted the findings.  An anesthesia provider who 
utilized ketamine in the control period, may not have worked, or worked rarely, during the post- 
dissemination period.  The analytic software utilized to track ketamine administration was able 
to identify CRNA’s, however all anesthesiologists and anesthesiology assistant data were 
aggregated together.  Ketamine is a controlled substance and comes in a variety of strengths.  At 
the study facility, the strength concentration to utilize sub-anesthetic dosing is not located in an 
area readily convenient to practitioners. 
To avoid bias, all anesthetics administered by the principal investigator were excluded.  
During the time frame that post-intervention data was being collected the author increased her 
involvement in cases that routinely receive ketamine due to another unrelated research project.  
This separate project removed cases that receive ketamine per protocol from other providers 
whose data would have otherwise been included.  The blinded nature of this study may have 
limited the impact on providers who would have otherwise been willing to attempt to change 
their practice.  Providers were not aware that utilization of ketamine was being tracked. 
Implications for Practice 
The results of this project support some of the challenges met when trying to impact 
change.  The passive diffusion model, as described by Lomas (1993), assumes that practitioners 
who read or hear about research proceed to adopt this information into their practice.  However 
evidence from systematic reviews regarding this subject suggest that continuing medical 
education (CME) methods have little direct impact on improving professional practice (Dawes 
et al., 2005).  Change champions are mentioned frequently in healthcare literature.  When 
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disseminating evidence that would result in a change in practice, having an influential champion 
spearhead this effort may be beneficial. 
Recommendations 
Evidence supports the utilization of ketamine in sub-anesthetic doses to improve the 
surgical experience for the patient.  Reduction in postoperative pain and reduction in opioid 
consumption with the related adverse side effects are important considerations.  A more 
aggressive, interactive method for dissemination of this evidence is required, if changes to 
practice are to be made.  Differences in the influence and power held by individuals may impact 
the success of interventions aimed at bringing the producers and users of research together 
(Rycroft-Malone, 2014).  Dissemination of information via a champion who clearly 
recommends adopting a change in practice would help to overcome inertia (Shaw, Howard, 
West, Crabtree, Nease, Tutt & Nutting, 2012).  Collaboration with the pharmacy to make 
ketamine, as packaged, for sub-anesthetic/analgesic dosing more conveniently accessible to 
anesthesia providers would reduce one of the barriers to utilization. 
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Appendix A:  Table 1 
Evaluation of Systematic Reviews 
 
Authors: Elia, N. & Tramèr, M.R. 
Year: 2004 
 
 
 Yes No Can’t 
answer 
Not 
Applicable 
Was an ‘a priori’ design provided? 
 
X    
Was there duplicate study selection and data extraction? 
 
X    
Was a comprehensive literature search performed? 
 
X    
Was the status of publication (i.e. grey literature) used as 
inclusion criteria? 
 
X    
Was a list of studies (included and excluded) provided? 
 
 X   
Were the characteristics of the included studies 
provided? 
 
 X   
Was the scientific quality of the included studies 
assessed and documented? 
 
X    
Was the scientific quality of the included studies used 
appropriately in formulation conclusions? 
X    
Were the methods used to combine the findings of the 
studies appropriate? 
 
X    
Was the likelihood of publication bias assessed? 
 
 X   
Was the conflict of interest stated? 
 
X    
 
AMSTAR measurement tool created to assess the methodological quality of systematic reviews 
Shea, et al. (2007) Development of AMSTAR: a measurement tool to assess the methodological 
quality of systematic reviews. BMC Medical Research Methodology 7, 10 
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Authors: Subramaniam, K., Subramaniam, B. and Steinbrook, R. A. 
Year:  2004 
 
 Yes No Can’t 
answer 
Not 
Applicable 
Was an ‘a priori’ design provided? 
 
X    
Was there duplicate study selection and data extraction? 
 
X    
Was a comprehensive literature search performed? 
 
X    
Was the status of publication (i.e. grey literature) used as 
inclusion criteria? 
 
X    
Was a list of studies (included and excluded) provided? 
 
X    
Were the characteristics of the included studies 
provided? 
 
 X   
Was the scientific quality of the included studies 
assessed and documented? 
 
X    
Was the scientific quality of the included studies used 
appropriately in formulation conclusions? 
X    
Were the methods used to combine the findings of the 
studies appropriate? 
 
X    
Was the likelihood of publication bias assessed? 
 
 X   
Was the conflict of interest stated? 
 
 X   
 
AMSTAR measurement tool created to assess the methodological quality of systematic reviews 
Shea, et al. (2007) Development of AMSTAR: a measurement tool to assess the methodological 
quality of systematic reviews. BMC Medical Research Methodology 7, 10 
 
 
 
 
 
 
 
 
 
 27 
 
 
Authors: Laskowski, K., Stirling, A., McKay, W. P. and Lim, H. J.  
Year: 2011 
 
 Yes No Can’t 
answer 
Not 
Applicable 
Was an ‘a priori’ design provided? 
 
X    
Was there duplicate study selection and data extraction? 
 
X    
Was a comprehensive literature search performed? 
 
X    
Was the status of publication (i.e. grey literature) used as 
inclusion criteria? 
 
X    
Was a list of studies (included and excluded) provided? 
 
 X   
Were the characteristics of the included studies 
provided? 
 
 X   
Was the scientific quality of the included studies 
assessed and documented? 
 
X    
Was the scientific quality of the included studies used 
appropriately in formulation conclusions? 
X    
Were the methods used to combine the findings of the 
studies appropriate? 
 
X    
Was the likelihood of publication bias assessed? 
 
X    
Was the conflict of interest stated? 
 
X    
 
AMSTAR measurement tool created to assess the methodological quality of systematic reviews 
Shea, et al. (2007) Development of AMSTAR: a measurement tool to assess the methodological 
quality of systematic reviews. BMC Medical Research Methodology 7, 10 
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Authors:  Bell, R. F., Dahl, J. B. and Kalso, E. A. 
Year:  2010 
 
 
 Yes No Can’t 
answer 
Not 
Applicable 
Was an ‘a priori’ design provided? 
 
X    
Was there duplicate study selection and data extraction? 
 
X    
Was a comprehensive literature search performed? 
 
X    
Was the status of publication (i.e. grey literature) used as 
inclusion criteria? 
 
X    
Was a list of studies (included and excluded) provided? 
 
X    
Were the characteristics of the included studies 
provided? 
 
 X   
Was the scientific quality of the included studies 
assessed and documented? 
 
X    
Was the scientific quality of the included studies used 
appropriately in formulation conclusions? 
X    
Were the methods used to combine the findings of the 
studies appropriate? 
 
X    
Was the likelihood of publication bias assessed? 
 
 X   
Was the conflict of interest stated? 
 
X    
 
AMSTAR measurement tool created to assess the methodological quality of systematic reviews 
Shea, et al. (2007) Development of AMSTAR: a measurement tool to assess the methodological 
quality of systematic reviews. BMC Medical Research Methodology 7, 10 
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Appendix E: Excluded Procedures 
 Bronchoscopy ** Bronchoscopy 
 Bronchoscopy, Laser 
 Bronchoscopy, Navigational 
 Bronchoscopy, Navigational ** Bronchoscopy, Ultrasound 
 Bronchoscopy, Ultrasound 
 Bronchoscopy, Ultrasound ** Bronchoscopy, Navigational 
 Colonoscopy ** Colonoscopy 
 Colonoscopy ** Endoscopic Ultrasound 
 Colonoscopy ** Esophagogastroduodenoscopy (EGD) 
 Colonoscopy ** Esophagogastroduodenoscopy (EGD) Esophagogastroduodenoscopy (EGD)   
US w/ FNA 
 Colonoscopy ** Esophagogastroduodenoscopy (EGD) w/ Peg Tube Insertion **     
Laryngoscopy, Direct 
 Cysto Insertion Stent / Removal ** Cystoscopy With Ureteroscopy 
 Cystoscopy ** Colonoscopy 
 Cystoscopy ** Examination Under Anesthesia 
 Cystoscopy With Ureteroscopy 
 Endoscopic Retrograde Cholangiopancreatography (ERCP) ** Esophagogastroduodenoscopy 
(EGD) 
 Endoscopic Ultrasound ** Colonoscopy ** Esophagogastroduodenoscopy (EGD) 
 Esophagogastroduodenoscopy (EGD) ** Bronchoscopy 
 Esophagogastroduodenoscopy (EGD) ** Colonoscopy 
 Esophagogastroduodenoscopy (EGD) ** Enteroscopy 
 Esophagogastroduodenoscopy (EGD) ** Flexible Sigmoidoscopy 
 Esophagogastroduodenoscopy (EGD) ** Manometry 
 Esophagogastroduodenoscopy (EGD) ** Transesophageal Echocardiogram 
 Esophagogastroduodenoscopy (EGD) ** US Paracentesis 
 Esophagogastroduodenoscopy (EGD) w/ Peg Tube Insertion 
 Esophagogastroduodenoscopy (EGD) w/ Peg Tube Insertion ** Tracheostomy 
 Esophagogastroduodenoscopy (EGD), US w/ FNA 
 Esophagogastroduodenoscopy (EGD), US w/ FNA ** Endoscopic Retrograde 
Cholangiopancreatography (ERCP) 
 Esophagogastroduodenoscopy (EGD)/Colonoscopy 
 Esophagogastroduodenoscopy (EGD)/Colonoscopy ** Colonoscopy 
 Esophagogastroduodenoscopy (EGD)/Flex Sigmoid 
 Examination Under Anesthesia ** Examination Under Anesthesia ** Cystoscopy 
 Excision Of ** Esophagogastroduodenoscopy (EGD) 
 Gastrostomy Tube Placement, Laparoscopic ** Bronchoscopy ** Bronchoscopy 
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